Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.
Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.
Obesity has many implications for injured workers, from being a catalyst for injuries to increasing healthcare costs and lengthening time away from work.
Injuries accompanied by mental health disorders can increase claim costs and delay recovery.
A new WCRI report utilizes data from 68,850 workers from 2017-2021.
Healthesystems’ VP of Clinical Services addresses COVID-19 disruptions to workers’ comp, along with helpful strategies
Healthesystems’ VP of Clinical Services discusses population trends, non-opioid pain therapies, and comorbidities with WorkCompWire.
